you could have purchased 145 for what you were planning on spending for 100 if you had waited til today. No worrries, the share price will be less tomorrow. buy away...
Sentiment: Strong Sell
NVIV is a solid investment ACTC on the other hand is a lottery ticket in a fixed game. Keep your eyes on SPHS, EXEL and ZGNX.
Meet the new boss, same as the old boss....http://www.bizjournals.com/boston/blog/bioflash/2014/01/rabin-out-as-ceo-of-advanced-cell.html
IMHO, the pps will continue its downward trend to ~2.00 before there is a turn around in the pps. The science on the other hand is a different story. Per press release from ACTC, 38 patients have been dosed. you need power analysis and 38 patients will not proved the needed power. They are several years form any type of PIII studies.